Surgery Partners (SGRY) and Bain Capital Conclude Discussions
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/21/2026
- Wall St indexes advance with boost from chips, Iran optimism
- Intel soars after Trump says Apple agreed to work with chipmaker on US production
- Apple CEO warns price hikes 'unavoidable' as chip costs bite - WSJ
- Wall Street scrambles to lift Micron price targets ahead of earnings
- SanDisk and Micron surge as Apple confirms memory price pass-through
- Zelenskiy: best guarantee of Europe's future is fast-track EU membership for Ukraine
- Needham Starts NeoVolta (NEOV) at Buy
- Tesla acquires AI hardware company for up to $2 billion in stock
- Bel Fuse acquires dataMate ethernet business for $16 million
- Fed: Nine Of 18 FOMC Participants Pencil In 2026 Rate Hike
Surgery Partners (SGRY) guidance reaffirmation 'positive' despite no Bain deal - Mizuho
June 17, 2025 3:22 PM EDTMizuho analyst Ann Hynes reiterated an Outperform rating and a $28.00 price target on Surgery Partners (NASDAQ: SGRY) amid today's sell-off, following the company's announcement that it has concluded its discussions with Bain Capital regarding a potential acquisition. The company's independent committee determined that its long-term potential as an independent, publicly-traded company... More
